Pfizer (PFE) Return on Capital Employed (QoQ) (2009 - 2026)

Pfizer (PFE) Return on Capital Employed (QoQ) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Novartis Ag 109.78 Bn 109.09 Bn -

Historic Data

Download Data
DateValue
Mar 29, 2026 9.00
Dec 31, 2025 889.00
Sep 28, 2025 -590.00
Jun 29, 2025 -774.00
Sep 29, 2024 159.00
Jun 30, 2024 413.00
Mar 31, 2024 820.00
Dec 31, 2023 -1,424.00
Oct 1, 2023 -1,480.00
Jul 2, 2023 -1,090.00
Oct 2, 2022 1,012.00
Jul 3, 2022 544.00
Oct 3, 2021 838.00
Jul 4, 2021 233.00
Sep 27, 2020 -30.00
Jun 28, 2020 -201.00
Mar 29, 2020 -659.00
Dec 31, 2019 18.00
Sep 29, 2019 193.00
Jun 30, 2019 53.00